Katherine A. Rybinski

Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration

Brian Tomkowicz, Katherine A. Rybinski, Brian Foley et al. · Proceedings of the National Academy of Sciences · 2007 · 153 citations · Full text

Medicine, Cell Biology, Oncology +17

MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity

Xin Cheng, Jing Li, Keigo Tanaka et al. · Molecular Cancer Therapeutics · 2018 · 92 citations

Medicine, Oncology, Pharmacology +16

The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity

Jianmin Lin, Jared Spidel, Christopher Maddage et al. · Cancer Biology & Therapy · 2013 · 54 citations · Full text

Medicine, Oncology, Pharmacology +16

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature

Katherine A. Rybinski, Hongxia Z. Imtiyaz, Barrie Mittica et al. · Oncotarget · 2015 · 48 citations · Full text

Medicine, Cell Biology, Oncology +15

Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging

Marlène C.H. Hekman, Otto C. Boerman, Desirée L. Bos et al. · Molecular Pharmaceutics · 2017 · 42 citations · Full text

Medicine, Gynecology, Oncology +17